Melilla

Ask VT AI
View News Summary
  • Novo Nordisk expands access to weight-loss drug Wegovy through telehealth partnerships, offering discounted rates as compounded GLP-1 alternatives become less available.
  • Coca-Cola's Q1 revenue falls, but shares rise on strong outlook and growth in emerging markets.
  • First Solar cuts 2025 outlook after Q1 earnings miss, citing tariffs and market pressures, but remains optimistic about long-term growth prospects.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Novo Nordisk expands access to weight-loss drug Wegovy through telehealth partnerships, offering discounted rates as compounded GLP-1 alternatives become less available.
  • Coca-Cola's Q1 revenue falls, but shares rise on strong outlook and growth in emerging markets.
  • First Solar cuts 2025 outlook after Q1 earnings miss, citing tariffs and market pressures, but remains optimistic about long-term growth prospects.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Melilla